PolarityTE to Participate in Corporate Access Event in San Francisco, January 13-15, 2020

SALT LAKE CITY–(BUSINESS WIRE)–PolarityTE, Inc. (Nasdaq: PTE), a biotechnology company developing and commercializing regenerative tissue products and biomaterials, announced today that senior management will host institutional investor and partnering meetings at the LifeSci Advisors Corporate Access Event taking place at the Sir Francis Drake Hotel in San Francisco, January 13-15, 2020.

To schedule a meeting with the PolarityTE management team, please register online here or by email to [email protected].

About PolarityTE®

PolarityTE is focused on transforming the lives of patients by discovering, designing and developing a range of regenerative tissue products and biomaterials for the fields of medicine, biomedical engineering and material sciences. Rather than manufacturing with synthetic and foreign materials within artificially engineered environments, PolarityTE manufactures products from the patient’s own tissue and uses the patient’s own body to support the regenerative process. From a small piece of healthy autologous tissue, the company creates a dynamic and self-propagating product designed to regenerate the target tissues. PolarityTE’s innovative method is intended to promote and accelerate growth of the patient’s tissues to undergo a form of effective regenerative healing. Learn more at www.PolarityTE.com – Welcome to the Shift®.

POLARITYTE, the POLARITYTE logo, WHERE SELF REGENERATES SELF, WELCOME TO THE SHIFT, and SKINTE are trademarks or registered trademarks of PolarityTE, Inc.

Contacts

Investors:
Rich Haerle

VP, Investor Relations

PolarityTE, Inc.

[email protected]
(385) 315-0697

Media:
Angela Ziegler

VP, Marketing and Public Relations

PolarityTE, Inc.

[email protected]
(385) 239-0363